medRxiv : the preprint server for health sciences

SSRI use during early COVID-19 and the risk of Long COVID symptoms in people with depression

Updated

Abstract

Low serotonin may play a role in the long-term effects of COVID-19.

  • Long COVID is characterized by a wide range of symptoms affecting various biological systems.
  • The diversity of Long COVID symptoms complicates the identification of specific mechanisms involved.
  • Selective serotonin reuptake inhibitors (SSRIs) may have the potential to prevent long-term effects associated with COVID-19.
  • Examining the relationship between SSRIs and specific Long COVID symptoms could reveal underlying mechanisms.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free